LumiraDx Revenue and Competitors
Estimated Revenue & Valuation
- LumiraDx's estimated annual revenue is currently $347.8M per year.
- LumiraDx's estimated revenue per employee is $378,000
Employee Data
- LumiraDx has 920 Employees.
- LumiraDx grew their employee count by -29% last year.
LumiraDx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.6M | 52 | 33% | N/A | N/A |
#2 | $33.2M | 123 | 21% | N/A | N/A |
#3 | $21.9M | 81 | -39% | N/A | N/A |
#4 | $37.3M | 138 | 5% | N/A | N/A |
#5 | $25.1M | 93 | 3% | N/A | N/A |
#6 | $6.9M | 32 | -22% | N/A | N/A |
#7 | $210.6M | 624 | 28% | N/A | N/A |
#8 | $69.2M | 233 | 9% | N/A | N/A |
#9 | $23.2M | 86 | 6% | N/A | N/A |
#10 | $28.6M | 106 | -1% | N/A | N/A |
What Is LumiraDx?
LumiraDx recognizes the need to provide more effective, cost-efficient healthcare for everyone. We make diagnostic-led care simpler and more accessible with smarter connected diagnostics and diagnostic-led care solutions to enable better outcomes: better health, better experiences and better value. Founded in 2014 by a group of entrepreneurs with a successful track record of building and scaling diagnostics and health IT businesses, LumiraDx is now expanding the number of representatives and subsidiaries in all continents.
keywords:N/AN/A
Total Funding
920
Number of Employees
$347.8M
Revenue (est)
-29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
LumiraDx News
LumiraDx (NASDAQ:LMDX) Downgraded to Sell at Zacks Investment Research. Posted by admin on Apr 28th, 2022. Share on Twitter Share on Facebook Share on...
LumiraDx Limited (NASDAQ:LMDX) Sees Significant Decrease in Short Interest. Posted by admin on Apr 19th, 2022. Share on Twitter Share on Facebook Share on...
LumiraDx (Nasdaq: LMDX) is a next-generation point of care diagnostics company that is transforming community-based healthcare. Founded in 2014,...
Mills has acted as a consultant for Abbott Diagnostics, Siemens Healthineers, and LumiraDx; his institution has received grants from Abbott ...
... outside the submitted work, and honoraria from Abbott Diagnostics, Siemens Healthineers, Roche Diagnostics, Singulex and LumiraDx.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $373.5M | 920 | N/A | N/A |
#2 | $206.5M | 922 | 4% | N/A |
#3 | $348.5M | 922 | 11% | N/A |
#4 | $348.9M | 923 | 17% | N/A |
#5 | $207M | 924 | 2% | N/A |
LumiraDx Executives
Name | Title |
---|---|
Steve McRoberts | Chief Risk Officer (Technical) |
David Walton | Chief Commercial Officer |
Nigel Lindner | Chief Innovation Officer |
Ron Zwanziger | CEO/Chairman/Director |
Jerry McAleer | Chief Scientist/Director |
David Scott | CTO/Director |
Dorian LeBlanc | Chief Financial Officer |
Yvonne Harrison | Cartoning tecnicion |
Carlos Armando | Chief Financial Officer |
Diana Catalano | Vice President Legal, North America |
Pooja Pathak | VP Platform Strategy |
Todd Storch | Vice President Of Engineering |
Steven Sepulveda | Vice President Of Corporate Accounts |
Leonard Way | Vice President Operations (Fast Lab) |
Giffin Daughtridge | VP/GM |
Veronique Ameye | Executive Vice President & General Counsel |
David Lang | Senior Vice President Strip Manufacturing & Innovation |
Kevin Cunningham | VP / GM |
Deborah Holmes | VP Talent Management |
Per Grufman | VP of R&D |
Timothy Blicharz | Vice President, Quality & Regulatory Affairs, North America |
Peter Scheu | President, North American Commercial Operations |
Peter Welch | VP Business Development |